What Lies Within
Will unlocking the secrets of the microbiome yield a promising new horizon for medicine?
sponsored by Quay Pharma
What does the microbiome mean for drug development? A growing number of pharmaceutical companies and biotechs are becoming interested in the trillions of microbes that live within our bodies – and how they impact our health. Microbiome research could lead to new approaches to targeting disease, either through live biotherapeutic products or traditional drug development approaches.
In this special supplement sponsored by Quay Pharma, experts from across the industry give their views on where the field of microbiome-based medicines is heading, and what the challenges will be moving forward. Featuring: Denise Kelly (Seventure), Ronnie Farquhar (Artugen Therapeutics), James Leigh (4D Pharma), Maireadh Pedersen and Ryan Wilson (Quay Pharma), James McIlroy (EnteroBiotix), Aoife Brennan (Synlogic), and Mike Romanos (Microbiotica).
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.